No clear evidence that most new cancer drugs enhance life

首页> 外文期刊>Nursing standard >No clear evidence that most new cancer drugs enhance life

【24h】

No clear evidence that most new cancer drugs enhance life

机译：没有明确的证据表明大多数新的癌症药物提升了生活

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Most cancer drugs approved in Europe between 2009 and 2013 entered the market without clear evidence they improved survival or quality of life. Even where drugs did show patient survival gains over existing treatments, these were often marginal, a study found.

机译：在2009年至2013年欧洲批准的大多数癌症药物在没有明确证据的情况下进入市场，他们改善了生存或生活质量。即使药物表现出患者存活率超过现有治疗，这些都仍然是边缘的，研究发现。

著录项

来源
《Nursing standard》 |2017年第9期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类护理学;
关键词

相似文献

外文文献
中文文献
专利

1. No clear evidence that most new cancer drugs enhance life [J] . Nursing standard . 2017,第9期

机译：没有明确的证据表明大多数新的癌症药物提升了生活
2. Suppressive oligodeoxynucleotides synergistically enhance antiproliferative effects of anticancer drugs in A549 human lung cancer cells [J] . Ryohei Takahashi, Takashi Sato, Dennis M. Klinman, International journal of oncology . 2012,第2期

机译：抑制性寡脱氧核苷酸协同增强抗癌药在A549人肺癌细胞中的抗增殖作用
3. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. [J] . Homma S, Ishii Y, Morishima Y Clinical cancer research: an official journal of the American Association for Cancer Research . 2009,第10期

机译：Nrf2增强人肺癌中的细胞增殖和对抗癌药的抗性。
4. DRUG REPOSITIONING: EVIDENCE FOR ANTI-CANCER EFFECT OF NON-CANCER DRUGS [C] . Jackie M. Wypij Conference of the American College of Veterinary Internal Medicine . 2014

机译：药物重新定位：非癌症药物抗癌作用的证据
5. Cancer nanotechnology: Ligand based nano-construct for the enhancement of antitumor activity of anticancer drugs in breast cancer. [D] . Upadhyay, Kamal Kumar. 2009

机译：癌症纳米技术：基于配体的纳米结构，可增强乳腺癌中抗癌药物的抗肿瘤活性。
6. Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13 [O] . Courtney Davis, Huseyin Naci, Evrim Gurpinar, 2017

机译：欧洲药品管理局批准的抗癌药物总体生存和生活质量受益证据的可得性：药物批准的回顾性队列研究2009-13
7. Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency:retrospective cohort study of drug approvals 2009-13 [O] . Davis Courtney, Naci Huseyin, Gurpinar Evrim, 2017

机译：获得欧洲药品管理局批准的关于癌症药物总体生存和生活质量的益处的证据：药物批准的回顾性队列研究2009-13

No clear evidence that most new cancer drugs enhance life

摘要

著录项

相似文献

相关主题

期刊订阅